HB Wealth Management LLC Purchases 2,478 Shares of Danaher Corporation $DHR

HB Wealth Management LLC boosted its position in Danaher Corporation (NYSE:DHRFree Report) by 4.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 54,013 shares of the conglomerate’s stock after purchasing an additional 2,478 shares during the period. HB Wealth Management LLC’s holdings in Danaher were worth $10,709,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Norges Bank bought a new position in shares of Danaher in the 2nd quarter worth approximately $1,979,503,000. Viking Global Investors LP grew its position in Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after buying an additional 2,455,994 shares during the period. Generation Investment Management LLP increased its holdings in Danaher by 56.2% during the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock valued at $980,914,000 after buying an additional 1,787,522 shares during the last quarter. Primecap Management Co. CA raised its position in Danaher by 924.2% in the second quarter. Primecap Management Co. CA now owns 1,239,320 shares of the conglomerate’s stock worth $244,815,000 after acquiring an additional 1,118,318 shares during the period. Finally, Vanguard Group Inc. raised its position in Danaher by 1.3% in the second quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after acquiring an additional 788,499 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares in the company, valued at approximately $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Teri List sold 3,298 shares of Danaher stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director owned 20,762 shares in the company, valued at approximately $4,702,593. This represents a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 30,248 shares of company stock worth $6,609,663. 11.10% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Morgan Stanley started coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective for the company. Evercore ISI reissued an “outperform” rating and set a $250.00 price target on shares of Danaher in a report on Monday. Wells Fargo & Company raised their price objective on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft lifted their price objective on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Twenty-one investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $249.92.

Check Out Our Latest Analysis on DHR

Danaher Price Performance

Shares of Danaher stock opened at $234.92 on Friday. The company has a market capitalization of $165.94 billion, a price-to-earnings ratio of 48.44, a PEG ratio of 4.19 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The stock’s 50-day simple moving average is $225.31 and its 200-day simple moving average is $210.22. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the company earned $1.71 EPS. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. As a group, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s payout ratio is 26.39%.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.